Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: What are they and which is better?

Your Location：

Home >

Browse articles >

Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: What are they and which is better?

REVIEW | Updated：2023-06-05

- Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: What are they and which is better?
- Lin-Lu Ma , Yun-Yun Wang , Zhi-Hua Yang , Di Huang , Hong Weng , Xian-Tao Zeng
- Military Medical Research Vol. 7, Issue 3, Pages: 359-370(2020)
- Affiliations：
  1.Center for Evidence-Based and Translational Medicine, Zhongnan Hospital, Wuhan University, 169 Donghu Road, Wuchang District, Wuhan 430071, Hubei, China.
  2.Department of Evidence-Based Medicine and Clinical Epidemiology, the Second Clinical College, Wuhan University, Wuhan 430071, China.
  3.Center for Evidence-Based and Translational Medicine, Wuhan University, Wuhan 430071, China.
  4.Global Health Institute, Wuhan University, Wuhan 430072, China.
- Author bio：
  * zengxiantao1128@163.com; zengxiantao@whucebtm.com
- Funds：
- DOI： 10.1186/s40779-020-00238-8
  CLC：
- Accepted：
Scan QR Code
DOI：
DOI：

Full Text(HTML)
Figs( 0 ) Tabs( 1 )
References
Publication Info
Metrics

摘要

Abstract

关键词

Keywords

references

11

Views

21

Downloads

26

CSCD

Alert me when the article has been cited

Submit

Tools

BibTeXDownload
EndnoteDownload
RefMan Download
NoteExpressDownload
NoteFirstDownload

Publicity Resources

Related Articles

Identifying prognostic factors for conservative treatment outcomes in servicemen with chronic exertional compartment syndrome treated at a rehabilitation center

Engineering of functional auditory neurons from human induced pluripotent stem cells

Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies

Frostbite: diagnosis, treatment, prognosis, and future directions

From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation

Related Author

Mariëtte Z. Meulekamp

Peter van der Wurff

Alfred van der Meer

Cees Lucas

Related Institution

Research and Development, Military Rehabilitation Centre

Department of Physiotherapy, HU University of Applied Sciences

Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Centre, University of Amsterdam